SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-055239
Filing Date
2021-10-29
Accepted
2021-10-29 06:10:09
Documents
3
Period of Report
2021-10-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea149578-8k_bespoke.htm 8-K 36226
2 STOCK PURCHASE AGREEMENT BY AND AMONG BETWEEN BESPOKE EXTRACTS, INC., DANIL POLL ea149578ex10-1_bespoke.htm EX-10.1 200806
3 CANCELLATION AND SATISFACTION OF DEBENTURE AGREEMENT BY AND BETWEEN BESPOKE EXTR ea149578ex10-2_bespoke.htm EX-10.2 19773
  Complete submission text file 0001213900-21-055239.txt   258555
Mailing Address 323 SUNNY ISLES BOULEVARD SUITE 700 SUNNY ISLES FL 33160
Business Address 323 SUNNY ISLES BOULEVARD SUITE 700 SUNNY ISLES FL 33160 855-633-3738
Bespoke Extracts, Inc. (Filer) CIK: 0001409197 (see all company filings)

IRS No.: 204743354 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 8-K | Act: 34 | File No.: 000-52759 | Film No.: 211360509
SIC: 2834 Pharmaceutical Preparations